<SEC-DOCUMENT>0001737287-20-000021-index.html : 20200423
<SEC-HEADER>0001737287-20-000021.hdr.sgml : 20200423
<ACCEPTANCE-DATETIME>20200423163454
ACCESSION NUMBER:		0001737287-20-000021
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		6
CONFORMED PERIOD OF REPORT:	20191231
FILED AS OF DATE:		20200423
DATE AS OF CHANGE:		20200423
EFFECTIVENESS DATE:		20200423

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Allogene Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001737287
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				823562771
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38693
		FILM NUMBER:		20811461

	BUSINESS ADDRESS:	
		STREET 1:		210 EAST GRAND AVENUE
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080
		BUSINESS PHONE:		(650) 457-2700

	MAIL ADDRESS:	
		STREET 1:		210 EAST GRAND AVENUE
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>allo-20200423xdef14axproxy.htm
<DESCRIPTION>DEF 14A
<TEXT>
Document 1 - file: allo-20200423xdef14axproxy.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>ceocomp4620201.jpg
<TEXT>
Document 2 - file: ceocomp4620201.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>drafproxyimage11.jpg
<TEXT>
Document 3 - file: drafproxyimage11.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>drafproxyimage12.jpg
<TEXT>
Document 4 - file: drafproxyimage12.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>neo2019compmix4620201.jpg
<TEXT>
Document 5 - file: neo2019compmix4620201.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>qualificationstable_4820201.jpg
<TEXT>
Document 6 - file: qualificationstable_4820201.jpg

</DOCUMENT>
</SEC-DOCUMENT>